David Weininger

1 month ago | sciencedirect.com | David Weininger

Accurately predicting the properties of molecules lies at the core of fundamental tasks for AI-aided drug discovery, which is promising to accelerate the design and discovery of new drugs by facilitating efficient screening of molecules [1], [2]. With the prosperity of machine learning (including deep learning), data-driven molecular representation learning has been widely applied to molecular property prediction (MPP) [3], [4], [5].

1 month ago | bostonglobe.com | Don Aucoin |Murray Whyte |Kate Tuttle |Karen Campbell |David Weininger

Marking the beloved, bombastic British painter’s 250th birthday, this exhibition brings together dozens of works from the Yale collection. Comprising an array of Turner’s beguiling watercolors alongside major oil paintings such as Dort or Dordrecht: The Dort Packet-Boat from Rotterdam Becalmed, 1818 (he had a knack for titles), it’s the biggest airing of the collection in decades.

Nov 15, 2024 | bostonglobe.com | David Weininger

Visits to Boston by guest orchestras have become increasingly rare over the years. So there’s always a sense of occasion when an orchestra’s tour brings it to Symphony Hall. And few ensembles create a sense of occasion like the storied Berlin Philharmonic, which returns here on Wednesday. When the Philharmonic was last in Boston, in 2022, it seemed to use the visit as an occasion to emphasize what was new about this venerable ensemble in the six years since it had last played here.

Oct 5, 2024 | bostonglobe.com | David Weininger

No piece in the classical canon creates a sense of occasion like Mahler’s Eighth Symphony, of which the Boston Symphony Orchestra gave the first of three performances on Friday. The frequency with which words like “epic” and “grandiose” attach themselves to this work is no accident. Completed in 1907, the Eighth requires huge forces: not only an expanded orchestra but two adult choruses, a children’s chorus, and eight vocal soloists.

Oct 2, 2024 | dx.doi.org | Tudor I. Oprea |David Weininger |Rishton Gilbert M |von Saal

This manuscript was originally submitted to BioSilico on May 26, 2003. It was not accepted for publication. Besides disagreeing with the major tenet of our opinion, one of the reviewers pointed to the absence of patents listing us as inventors. With 12 granted patents between us, this concern is moot. This manuscript was based on my multiple conversations with David Weininger, a cheminformatics visionary who passed away in November 2016.